Schizophrenia Research
Volume 124, Issue 1 , Pages 169-175 , December 2010

The relationships between schizophrenia symptom dimensions and executive functioning components

  • Laura K. Clark

      Affiliations

    • University of Indianapolis, School of Psychological Sciences, 1400 East Hanna Avenue, Indianapolis, IN 46227, USA
    • ,
  • Debbie Warman

      Affiliations

    • University of Indianapolis, School of Psychological Sciences, 1400 East Hanna Avenue, Indianapolis, IN 46227, USA
    • ,
  • Paul H. Lysaker

      Affiliations

    • Roudebush VA Medical Center (116h), 1481 West 10th St, Indianapolis, IN 46202, USA
    • Indiana University School of Medicine, USA
    • Corresponding Author InformationCorresponding author. Roudebush VA Medical Center (116h) 1481 West 10th St Indianapolis IN 46202, USA. Tel.: +1 317 988 2546.

Received 12 April 2010 ,Revised 27 July 2010 ,Accepted 3 August 2010.

References 

  1. Addington J, Addington D, Maticka-Tyndale E. Cognitive functioning and positive and negative symptoms in schizophrenia. Schizophr. Res. 1991;5:123–134
  2. Albus M, Hubmann W, Ehrenberg C, Forcht U, Mohr F, Sobizack N, et al. Neuropsychological impairments in first episode and chronic schizophrenia patients. Eur. Arch. Psychiatry Clin. Neurosci. 1996;246:249–255
  3. Alptekin K, Akvardar Y, Akdede B, Dumlu K, Isik D, Pirincci F, et al. Is quality of life associated with cognitive impairment in schizophrenia?. Prog. Neuropsychopharmacol. 2005;29:239–244
  4. Basso MR, Nasrallah HA, Olson SC, Bornstein RA. Neuropsychological correlates of negative, disorganized, and psychotic symptoms in schizophrenia. Schizophr. Res. 1998;31:99–111
  5. Baxter RD, Liddle PF. Neuropsychological deficits associated with schizophrenic syndromes. Schizophr. Res. 1998;30:239–249
  6. Bell MD, Lysaker PH, Beam-Goulet JL, Milstein RM, Lindenmayer JP. Five component model of schizophrenia: assessing the factorial invariance of the Positive and Negative Syndrome Scale. Psychiatry Res. 1994;52:295–303
  7. Benson DF, Miller BL. Frontal lobes: clinical and anatomic aspects. In:  Feinberg TE,  Farah MJ editor. Behavioral Neurology and Neuropsychology. New York: McGraw Hill; 1997;p. 401–408
  8. Berman I, Viegner B, Merson A, Allan E, Pappas D, Green AI. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia. Schizophr. Res. 1997;25:1–10
  9. Burgess PW, Shallice T. The Hayling and Brixton Tests. Thurston, Suffolk, England: Thames Valley Test Company; 1997;
  10. Busch RM, McBride A, Curtiss G, Vanderploeg RD. The components of executive functioning in traumatic brain injury. J. Clin. Neuropsychol. 2005;27:1022–1032
  11. Cascella NG, Testa SM, Meyer SM, Vani AR, Diaz-Asper CM, Pearlson GD, et al. Neuropsychological impairment in deficit vs. non-deficit schizophrenia. J. Psychiatr. Res. 2008;42:930–937
  12. Chan RCK, Chen EYH, Cheung EFC, Cheung HK. Executive dysfunctions in schizophrenia: relationships to clinical manifestation. Eur. Arch. Psychiatry Clin. Neurosci. 2004;254:256–262
  13. Chan RCK, Chen EYH, Cheung EFC, Chen RYL, Cheung HK. The components of executive functioning in a cohort of patients with chronic schizophrenia: a multiple single-case study design. Schizophr. Res. 2006;81:173–189
  14. Chan RCK, Chen EYH, Law CW. Specific executive dysfunction in patients with first-episode medication-naïve schizophrenia. Schizophr. Res. 2006;82:51–64
  15. Cuesta MJ, Peralta V. Cognitive disorder in the positive, negative, and disorganization syndromes in schizophrenia. Psychiatry Res. 1995;58:227–235
  16. Delis DC, Kaplan E, Kramer JH. Delis Kaplan Executive Function System: Technical Manual. San Antonio: The Psychological Corporation; 2001;
  17. Donohoe G, Robertson IH. Can specific deficits in executive functioning explain the negative symptoms of schizophrenia? A review. Neurocase. 2003;9:97–108
  18. Donohoe G, Corvin A, Robertson IH. Evidence that specific executive functions predict symptom variance among schizophrenia patients with a predominantly negative symptom profile. Cogn. Neuropsychiatry. 2006;11:13–32
  19. Eckman PS, Shean GD. Impairment in test performance and symptom dimensions of schizophrenia. J. Psychiatr. Res. 2000;34:147–153
  20. Evans JD, Bond GR, Meyer PS, Kim HW, Lysaker PH, Gibson PJ, et al. Cognitive and clinical predictors of success in vocational rehabilitation in schizophrenia. Schizophr. Res. 2004;70:331–342
  21. Gorsuch RL. Factor Analysis. second ed.. Hillsdale: Erlbaum; 1983;
  22. Greenwood KE, Morris R, Sigmundsson T, Landau S, Wykes T. Executive functioning in schizophrenia with symptom profile and chronicity. J. Int. Neuropsychol. Soc. 2008;14:782–792
  23. Hedden T, Yoon C. Individual differences in executive processing predict susceptibility to interference in verbal working memory. Neuropsychology. 2006;20:511–528
  24. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12:426–445
  25. Himelhoch S, Taylor SF, Goldman RS, Tandon R. Frontal lobe tasks, antipsychotic medication, and schizophrenia syndromes. Biol. Psychiatry. 1996;39:227–229
  26. Homack S, Lee D, Riccio CA. Test review: Delis–Kaplan Executive Function System. J. Clin. Exp. Neuropsychol. 2005;27:599–609
  27. Johnson-Selfridge M, Zalewski C. Moderator variables of executive functioning in schizophrenia: meta-analytic findings. Schizophr. Bull. 2001;27:305–316
  28. Kay SR, Fizszbein A, Opler LA. The positive and negative syndrome scale for schizophrenia. Schizophr. Bull. 1987;13:261–276
  29. Liddle PF. Schizophrenic syndromes, cognitive performance, and neurological dysfunction. Psychol. Med. 1987;17:49–57
  30. Liddle PF, Morris DL. Schizophrenic syndromes and frontal lobe performance. Br. J. Psychiatry. 1991;158:340–345
  31. Logan GD, Cowan WB. On the ability to inhibit thought and action: a theory of an act of control. Psychol. Rev. 1984;91:295–327
  32. Lysaker PH, Bell MD, Zito WS, Bioty SM. Social skills at work: deficits and predictors of improvement in schizophrenia. J. Nerv. Ment. Dis. 1995;183:688–692
  33. Lysaker PH, Warman DM, Dimaggio G, Procacci M, Larocca VA, Clark LK, et al. Metacognition in schizophrenia: associations with multiple assessments of executive function. J. Nerv. Ment. Dis. 2008;196:384–389
  34. Mahurin RK, Velligan DI, Miller AL. Executive-frontal lobe cognitive dysfunction in schizophrenia: a symptom subtype analysis. Psychiatry Res. 1998;79:139–149
  35. Medalia A, Lim R. Treatment of cognitive dysfunction in psychiatric disorders. J. Psychiatr. Pract. 2004;10:12–25
  36. Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, Wager TD. The unity and diversity of executive functions and their contributions to complex “frontal lobe” tasks: a latent variable analysis. Cogn. Psychol. 2000;41:49–100
  37. Moritz S, Andreasen B, Jacobsen D, Mersmann K, Wilke U, Lambert M, et al. Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics. Eur. Psychiatry. 2001;16:354–361
  38. Norman RMG, Malla AK, Morrison-Stewart SL, Helmes E, Williamson PC, Thomas J, et al. Neuropsychological correlates of syndromes in schizophrenia. Brit. J. Psychiat. 1997;170:134–139
  39. Norman DA, Shallice T. Attention and action: willed and automatic control of behaviour (CHIP Report No. 9).. San Diego: University of California. 1980;
  40. O'Leary DS, Flaum M, Kesler ML, Flashman LA, Arndt S, Andreasen NC. Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia. J. Neuropsychiatry Clin. Neurosci. 2000;12:4–15
  41. Penades R, Catalan R, Salamero M, Boget T, Puig O, Guarch J, et al. Cognitive remediation therapy for outpatients with chronic schizophrenia: a controlled and randomized study. Schizophr. Res. 2006;87:323–331
  42. Savilla K, Kettler L, Galletly C. Relationship between cognitive deficits, symptoms and quality of life in schizophrenia. Aust. NZ J. Psychiatry. 2008;42:496–504
  43. Shallice T. From Neuropsychology to Mental Structure. Cambridge, UK: Cambridge University Press; 1988;
  44. Spitzer R, Gibbon M, First M. Structured Clinical Interview for DSM IV. New York: Biometrics Research; 1994;
  45. St. Clair-Thompson HL, Gathercole SE. Executive functions and achievements in school: shifting, updating, inhibition, and working memory. Q. J. Exp. Psychol. 2006;59:745–759
  46. Tabachnick BG, Fidell LS. Using Multivariate Statistics. third ed.. New York: Harper Collins; 1996;
  47. Van Der Does AJW, Dingemans AJ, Linszen DH, Nutger MA, Scholte WF. Symptom dimensions and cognitive and social functioning in recent-onset schizophrenia. Psychol. Med. 1993;23:745–753
  48. Voruganti LNP, Heslegrave RJ, Awad AG. Neurocognitive correlates of positive and negative syndromes in schizophrenia. Can. J. Psychiatry. 1997;42:1066–1071
  49. Weintraub D, Moberg PJ, Culbertson WC, Duda JE, Katz IR, Stern MB. Dimensions of executive function in Parkinson's disease. Dement. Geriatr. Cogn. 2005;20:140–144
  50. Zakzanis KK. Neuropsychological correlates of positive vs. negative schizophrenic symptomatology. Schizophr. Res. 1998;29:227–233

PII: S0920-9964(10)01450-7

doi: 10.1016/j.schres.2010.08.004

Schizophrenia Research
Volume 124, Issue 1 , Pages 169-175 , December 2010

Article Tools